Baricitinib vs Deucravacitinib
Baricitinib vs Deucravacitinib: Overview
This comparison examines the pharmacological differences between Baricitinib and Deucravacitinib.
Mechanism of Action
Baricitinib: Selective JAK1 and JAK2 inhibitor blocking cytokine signaling involved in inflammation.
Pharmacokinetics
Half-life: Baricitinib — 12 hours.
Chemical Properties
Molecular Formula: Baricitinib — C16H17N7O2S.
Molecular Weight: Baricitinib — 371.4170 g/mol.
Type: Baricitinib — Small molecule; Deucravacitinib — Small molecule.